tirzepatide supreme court Eli Lilly Sues Compounders Over Unauthorized Copies of Weight-Loss Drugs Lilly Takes Four Compounders to

In clinical trials, it has produced some of the most significant weight-loss results of any GLP-1 medication currently available.* Compounded tirzepatide injections have also become widely available through telehealth platforms, making the medication more accessible for more people

Results demonstrated: Average weight loss: 14.9% of body weight Success rate breakdown: 86.4% lost at least 5% of body weight 69.1% lost at least 10% of body weight 50.5% lost at least 15% of body weight 32% lost at least 20% of body weight That same 220-pound person losing 14.9% would drop about 33 pounds to reach 187 pounds

Improved Health Outcomes Patients in Charlotte have noticed improvements not only in their weight but also in metabolism

Blood glucose measurements provide immediate feedback on how well tirzepatide controls blood sugar between meals

Freezing reconstituted tirzepatide destroys the peptide

This dual mechanism is thought to be more effective than medications that target only one of these pathways